Acute Lymphoblastic Leukemia: Risk Stratification
2 意见
• 06/15/23
0
0
嵌入
Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk stratification process in acute lymphoblastic leukemia, incorporating patient age, molecular subtype, and minimal residual disease status.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论